To develop a pre-emptive genetic test that comprises multiple predisposing alleles for the prevention of phenytoin-related severe cutaneous adverse reactions (SCARs), three sets of patients with phenytoin-SCAR and drug-tolerant controls from Taiwan, Thailand, and Japan, were enrolled for this study. In addition to cytochrome P450 (CYP)2C9*3, we found that HLA-B*13:01, HLA-B*15:02, and HLA-B*51:01 were significantly associated with phenytoin hypersensitivity with distinct phenotypic specificities. Strikingly, we showed an increase in predictive sensitivity of concurrently testing CYP2C9*3/HLA-B*13:01/HLA-B*15:02/HLA-B*51:01 from 30.5-71.9% for selecting the individuals with the risk of developing phenytoin-SCAR in Taiwanese cohorts, accompanied by a specificity of 77.7% (combined sensitivity, 64.7%; specificity, 71.9% for three Asian populations). Meta-analysis of the four combined risk alleles showed significant associations with phenytoin-SCAR in three Asian populations. In conclusion, combining the assessment of risk alleles of HLA and CYP2C9 potentiated the usefulness of predictive genetic tests to prevent phenytoin hypersensitivity in Asians.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cpt.1190 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with the use of antiseizure medications-An overview of clinical data.
Seizure
January 2025
Department of Pharmacology, J.K.K. Nattraja College of Pharmacy, Komarapalayam, India. Electronic address:
The United States Food and Drug Administration (US FDA) released a warning regarding Drug Reactions with Eosinophilia and Systemic Symptoms (DRESS) linked to the use of antiseizure drugs, including levetiracetam and clobazam, on November 28, 2023. Hence, our review focuses on DRESS associated with the use of antiseizure drugs, including Levetiracetam, Clobazam, Carbamazepine, Phenytoin, Phenobarbital, Valproate, Oxcarbazepine, and Lamotrigine. The online databases, such as Medline/Pubmed/PMC, Scopus, Web of Science, Google Scholar, Science Direct, Ebsco, Embase, and reference lists, were searched for relevant publications.
View Article and Find Full Text PDFCOVID-19 and severe cutaneous allergic reactions to sulfonamides.
Allergy Asthma Proc
November 2024
From the Section of Allergy, Asthma and Immunology, Department of Medicine, Pennsylvania State College of Medicine, Hershey, Pennsylvania and.
Sulfonamides are associated with severe cutaneous adverse reactions (SCARs). Coronavirus disease 2019 (COVID-19) triggers an immune response, which may increase the likelihood of developing a hypersensitivity reaction. We sought to explore the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the probability of developing SCARs and/or erythema multiforme (EM) reactions to sulfonamides.
View Article and Find Full Text PDFallele frequencies and implications for pharmacogenetics in the Kuwaiti population.
Front Pharmacol
October 2024
Genetics and Bioinformatics Department, Dasman Diabetes Institute, Kuwait City, Kuwait.
Unlabelled: This study explores the frequency of human leukocyte antigen (HLA) genes, particularly alleles, within the Kuwaiti population. We aim to identify alleles with known associations to adverse drug reactions (ADRs) based on existing literature. We focus on the gene due to its well-documented associations with severe cutaneous adverse reactions and the extensive pharmacogenetic research supporting its clinical relevance.
View Article and Find Full Text PDFDrug-induced hypersensitivity syndrome due to phenytoin: Case report and review of the literature.
Medicine (Baltimore)
September 2024
Chongqing Medical University, Yuzhong District, Chongqing, China.
Article Synopsis
- Drug hypersensitivity syndrome (DIHS) is a serious reaction to medication that can cause fever, rashes, and liver problems, often linked to antiepileptic drugs like phenytoin sodium.
- A 15-year-old boy developed DIHS after taking phenytoin, showing symptoms like fever, sore throat, rash, and jaundice.
- Treatment with steroids improved his symptoms quickly, and after 30 months, he had no further health issues or complications.
Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review.
BMC Endocr Disord
September 2024
Department of endocrinology, Peking Union Medical College Hospital, Beijing, China, 100730.
Article Synopsis
- Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious skin reactions caused by drug hypersensitivity, leading to severe skin damage and possible complications like fulminant type 1 diabetes mellitus (FT1DM).
- A 73-year-old woman developed SJS/TEN after taking carbamazepine and phenytoin, followed by hyperglycemia and diabetic ketoacidosis 20 days later, with low C-peptide levels confirming FT1DM.
- The case highlights the importance of monitoring blood glucose levels in patients with SJS/TEN and suggests that a combination of treatments, including rehydration, insulin, and intravenous immunoglobulin, can improve patient outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!